Article
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
Circulation. Cardiovascular genetics - 1 Aug 2011
Trenk Dietmar, Hochholzer Willibald, Fromm Martin F, Zolk Oliver, Valina Christian M, Stratz Christian, Neumann Franz-Josef
Abstract excerpt
BACKGROUND: Recently published data indicate that the paraoxonase-1 (PON1) Q192R genotype-and not as previously shown activity of cytochrome P450 (CYP) 2C19-is the major determinant of metabolic bioactivation of clopidogrel and thereby variability of antiplatelet effect of clopidogrel. We sought...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
